Dear Dr. Donohue: I am a 74-year-old man. I have not had physical exams regularly until recently. I took a pre-op exam for cataract surgery, and one of the numbers noted was for PSA. It was 6.1. I have no prostate gland symptoms other than an occasional slow urinary stream.Dr. ...
Study: PSA level changes important; Prostate cancer fatality rate seems linked to how rapidly test numbers fluctuateASSOCIATED PRESS
Another test is done on a blood sample to determine the level of a protein (prostate-specific antigen or PSA) produced by prostate cells. The PSA test may indicate a person has a higher chance of having prostate cancer but controversies about the test exist (see following slide). The patien...
ContextSexual activity has been hypothesized to play a role in the development of prostate cancer, but epidemiological data are virtually limited to
When testing for prostate cancer, as many as 75% of men with a raised prostate-specific antigen (PSA) have a benign biopsy result. Little is known about the psychological effect of this result for these men. In all, 330 men participating in the prostate
PSA tests in the Cambridge area In the Cambridge area from 1 January 1996 to 31 December 2002 (that is the period during which we had PSA data linked to cancer registry data), 8894 men had at least one PSA test, of whom 23% (2053) were 50–59 years, 30% (2701) were 60–69 yea...
You probably had a blood test to check your levels of PSA -- a protein called prostate-specific antigen -- before your doctor told you that you haveprostate cancer. You'll still get those tests now that your cancer has spread beyond your prostate. ...
Prof Cheng’s PSA was at 17.8 when he was first diagnosed with prostate cancer. He said: In some (overseas) centres, if you have prostate cancer with a PSA of 17, the top surgeons will not operate on you because it would tarnish their results. ...
Dependent, non-normally distributed variables were compared with Wilcoxon signed-rank test. Pearson’s correlation analysis was also used. Data obtained were analyzed by testing the difference between two proportions for incidence of prostate cancer in each group and evaluation of the ΔPSA. ...
This cluster randomized trial evaluates the effect of a single prostate-specific antigen (PSA) screening test on 10-year prostate cancer–specific